New combo therapy targets Hard-to-Treat prostate cancer
NCT ID NCT06533644
First seen Nov 19, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This study tests a new treatment called SYNC-T therapy (SV-102) for men with metastatic castration-resistant prostate cancer, a type that has stopped responding to hormone therapy. The goal is to find the safest and most effective dose and see if it can shrink tumors or slow the disease. About 91 men will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Duly Health
RECRUITINGLisle, Illinois, 60532, United States
-
Houston Metro Urology
NOT_YET_RECRUITINGHouston, Texas, 77027, United States
-
Mayo Clinic
NOT_YET_RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic
NOT_YET_RECRUITINGJacksonville, Florida, 32224, United States
-
Medical College of Wisconsin
NOT_YET_RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Mercy Hospital
RECRUITINGSt Louis, Missouri, 63141, United States
-
Michigan Institute of Urology
RECRUITINGTroy, Michigan, 48084, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
NYU Langone
RECRUITINGNew York, New York, 10016, United States
-
Northwell Health
RECRUITINGLake Success, New York, 11042, United States
-
Ohio State University
NOT_YET_RECRUITINGColumbus, Ohio, 43201, United States
-
University of Arizona Cancer Center
RECRUITINGTucson, Arizona, 85719, United States
-
University of California-Davis
NOT_YET_RECRUITINGSacramento, California, 95817, United States
-
University of Chicago
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68105, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
Weill Cornell
RECRUITINGNew York, New York, 10065, United States
-
Wichita Urology
RECRUITINGWichita, Kansas, 67226, United States
Conditions
Explore the condition pages connected to this study.